This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ji, I. Articles by Ji, T. H. Search for Related Content PubMed PubMed Citation Articles by Ji, I. Articles by Ji, T. H.

Trans-Activation of Mutant Follicle-Stimulating Hormone Receptors Selectively Generates Only One of Two Hormone Signals

Department of Chemistry (I.J., C.L., M.J., G.A.S., T.H.J.), University of Kentucky, Lexington, Kentucky 40506-0055; and School of Biotechnology and Biomedical Science (Y.K.), InJe University, GimHae 621-749, Korea

Address all correspondence and requests for reprints to: Tae H. Ji, Department of Chemistry, University of Kentucky, Lexington, Kentucky 40506-0055. E-mail: tji{at}uky.edu

Previously, we reported that a liganded LH receptor (LHR) is capable of activating itself (cis-activation) and other nonliganded LHRs to induce cAMP (trans-activation). Trans-activation of the LHR raises two crucial questions. Is trans-activation unique to LHR or common to other G protein-coupled receptors? Does trans-activation stimulate phospholipase Cß as it does adenylyl cyclase? To address these questions, two types of novel FSH receptors (FSHRs) were constructed, one defective in hormone binding and the other defective in signal generation. The FSHR, a G protein-coupled receptor, comprises two major domains, the N-terminal extracellular exodomain that binds the hormone and the membrane-associated endodomain that generates the hormone signals. For signal defective receptors, the exodomain was attached to glycosyl phosphatidylinositol (ExoGPI) or the transmembrane domain of CD8 immune receptor (ExoCD). ExoGPI and ExoCD can trans-activate another nonliganded FSH. Surprisingly, the trans-activation generates a signal to activate either adenylyl cyclase or phospholipase Cß, but not both. These results indicate that trans-activation in these mutant receptors is selective and limited in signal generation, thus providing new approaches to investigating the generation of different hormone signals and a novel means to selectively generate a particular hormone signal. Our data also suggest that the FSHR’s exodomain could not trans-activate LHR.

This article has been cited by other articles:

				A. M. Svendsen, M. Vrecl, T. M. Ellis, A. Heding, J. B. Kristensen, J. D. Wade, R. A. D. Bathgate, P. De Meyts, and J. Nohr Cooperative Binding of Insulin-Like Peptide 3 to a Dimeric Relaxin Family Peptide Receptor 2 Endocrinology, March 1, 2008; 149(3): 1113 - 1120. [Abstract] [Full Text] [PDF]

				R. M. Thomas, C. A. Nechamen, J. E. Mazurkiewicz, M. Muda, S. Palmer, and J. A. Dias Follice-Stimulating Hormone Receptor Forms Oligomers and Shows Evidence of Carboxyl-Terminal Proteolytic Processing Endocrinology, May 1, 2007; 148(5): 1987 - 1995. [Abstract] [Full Text] [PDF]

				W. Guo, L. Shi, M. Filizola, H. Weinstein, and J. A. Javitch From The Cover: Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface determine activation PNAS, November 29, 2005; 102(48): 17495 - 17500. [Abstract] [Full Text] [PDF]